R R Miller

1.8k total citations
38 papers, 1.5k citations indexed

About

R R Miller is a scholar working on Cancer Research, Pharmacology and Molecular Biology. According to data from OpenAlex, R R Miller has authored 38 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cancer Research, 8 papers in Pharmacology and 5 papers in Molecular Biology. Recurrent topics in R R Miller's work include Carcinogens and Genotoxicity Assessment (15 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Immunotoxicology and immune responses (3 papers). R R Miller is often cited by papers focused on Carcinogens and Genotoxicity Assessment (15 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Immunotoxicology and immune responses (3 papers). R R Miller collaborates with scholars based in United States, India and Canada. R R Miller's co-authors include Michael J. McKenna, Alan Poole, Emile A. Hermann, Patrick W. Langvardt, George A. Doss, Bernard A. Schwetz, John T. Young, Ralph A. Stearns, Willis J. Potts and S H Chiu and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Environmental Health Perspectives and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

R R Miller

37 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R R Miller United States 20 507 366 268 252 204 38 1.5k
I.F. Gaunt United Kingdom 22 468 0.9× 557 1.5× 380 1.4× 213 0.8× 184 0.9× 135 2.0k
Michele A. Medinsky United States 26 959 1.9× 685 1.9× 431 1.6× 309 1.2× 137 0.7× 75 1.9k
George Cruzan United States 19 459 0.9× 347 0.9× 180 0.7× 128 0.5× 120 0.6× 32 1000
H.P. Til Netherlands 20 312 0.6× 397 1.1× 420 1.6× 96 0.4× 186 0.9× 43 1.6k
Matthew S. Bogdanffy United States 26 742 1.5× 560 1.5× 492 1.8× 124 0.5× 186 0.9× 71 1.9k
Robert P. Beliles United States 12 408 0.8× 545 1.5× 255 1.0× 360 1.4× 151 0.7× 29 1.7k
J.C. Ramsey United States 14 542 1.1× 582 1.6× 129 0.5× 234 0.9× 162 0.8× 22 1.3k
D. C. Villeneuve Canada 24 416 0.8× 1.1k 2.9× 210 0.8× 244 1.0× 192 0.9× 130 1.9k
Clay B. Frederick United States 19 265 0.5× 186 0.5× 272 1.0× 170 0.7× 105 0.5× 42 1.1k
John Whysner United States 25 596 1.2× 395 1.1× 716 2.7× 281 1.1× 204 1.0× 44 2.0k

Countries citing papers authored by R R Miller

Since Specialization
Citations

This map shows the geographic impact of R R Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R R Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R R Miller more than expected).

Fields of papers citing papers by R R Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R R Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R R Miller. The network helps show where R R Miller may publish in the future.

Co-authorship network of co-authors of R R Miller

This figure shows the co-authorship network connecting the top 25 collaborators of R R Miller. A scholar is included among the top collaborators of R R Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R R Miller. R R Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harper, James M., et al.. (2005). Hyperglycemia, impaired glucose tolerance and elevated glycated hemoglobin levels in a long-lived mouse stock. Experimental Gerontology. 40(4). 303–314. 9 indexed citations
2.
Karanam, Bindhu V., R R Miller, Adria Colletti, et al.. (1998). Disposition of L-732,531, a potent immunosuppressant, in rats and baboons.. PubMed. 26(10). 949–57. 7 indexed citations
3.
Balani, Suresh K., Xin Xu, Vijaya S. Pratha, et al.. (1997). Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile.. PubMed. 25(11). 1282–7. 75 indexed citations
4.
Cushman, Janette R., et al.. (1997). Subchronic Inhalation Studies of Styrene in CD Rats and CD-1 Mice. Toxicological Sciences. 35(2). 152–165. 1 indexed citations
5.
Vincent, S H, Avery Rosegay, David Dean, et al.. (1996). Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.. Drug Metabolism and Disposition. 24(12). 1369–1377. 16 indexed citations
6.
Huskey, Su-Er W., George A. Doss, R R Miller, William R. Schoen, & S H Chiu. (1994). N-glucuronidation reactions. II. Relative N-glucuronidation reactivity of methylbiphenyl tetrazole, methylbiphenyl triazole, and methylbiphenyl imidazole in rat, monkey, and human hepatic microsomes.. Drug Metabolism and Disposition. 22(4). 651–658. 25 indexed citations
7.
Miller, R R, et al.. (1994). Styrene Production, Use, and Human Exposure. Critical Reviews in Toxicology. 24(sup1). S1–S10. 181 indexed citations
8.
Stearns, Ralph A., R R Miller, Byron H. Arison, et al.. (1993). Evidence for a 1,2-hydride shift in the microsomal metabolism of the heterocycle L-158,338, a nonpeptide angiotensin II receptor antagonist.. Drug Metabolism and Disposition. 21(4). 670–676. 1 indexed citations
9.
Breslin, William J., et al.. (1991). Hemolytic Activity of Ethylene Glycol Phenyl Ether (EGPE) in Rabbits. Toxicological Sciences. 17(3). 466–481. 3 indexed citations
10.
Stearns, Ralph A., et al.. (1991). Synthesis and identification of a novel tetrazole metabolite of the angiotensin II receptor antagonist DuP 753.. Drug Metabolism and Disposition. 19(6). 1160–1162. 24 indexed citations
11.
Miller, R R. (1987). Metabolism and Disposition of Glycol Ethers. Drug Metabolism Reviews. 18(1). 1–22. 34 indexed citations
12.
Nitschke, K.D., Ralph R. Albee, Joel L. Mattsson, & R R Miller. (1986). Incapacitation and Treatment of Rats Exposed to a Lethal Dose of Sulfuryl Fluoride. Toxicological Sciences. 7(4). 664–670. 1 indexed citations
13.
Miller, R R, John T. Young, R.J. Kociba, et al.. (1985). Chronic Toxicity and Oncogenicity Bioassay of Inhaled Ethyl Acrylate in Fischer 344 Rats and B6c3f1 Mice. Drug and Chemical Toxicology. 8(1-2). 1–42. 92 indexed citations
14.
Miller, R R, et al.. (1984). Propylene glycol monomethyl ether acetate (PGMEA) metabolism, disposition, and short-term vapor inhalation toxicity studies. Toxicology and Applied Pharmacology. 75(3). 521–530. 57 indexed citations
15.
Miller, R R, et al.. (1984). Ethylene glycol monomethyl ether and propylene glycol monomethyl ether: metabolism, disposition, and subchronic inhalation toxicity studies.. Environmental Health Perspectives. 57. 233–239. 60 indexed citations
16.
Miller, R R, et al.. (1983). Ethylene glycol monomethyl ether. I. Subchronic vapor inhalation study with rats and rabbits. Fundamental and Applied Toxicology. 3(1). 49–54. 49 indexed citations
17.
Miller, R R, et al.. (1982). Toxicity of methoxyacetic acid in rats. Fundamental and Applied Toxicology. 2(4). 158–160. 103 indexed citations
18.
Ribeiro, Lair G.T., et al.. (1981). Efeitos do D-600 (metoxi-verapamil) na mortalidade e tamanho do infarto apos oclusao coronariana em ratos.. Arquivos Brasileiros de Cardiologia. 1 indexed citations
19.
Miller, R R, et al.. (1981). Inhalation toxicity of acrylic acidA. Fundamental and Applied Toxicology. 1(3). 271–277. 57 indexed citations
20.
Miller, R R, et al.. (1980). Improved methodology for generating controlled test atmospheres. American Industrial Hygiene Association Journal. 41(11). 844–846. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by I.F. Gaunt Breakdown of academic impact, for papers by Michele A. Medinsky Breakdown of academic impact, for papers by George Cruzan Breakdown of academic impact, for papers by H.P. Til Breakdown of academic impact, for papers by Matthew S. Bogdanffy Breakdown of academic impact, for papers by Robert P. Beliles Breakdown of academic impact, for papers by J.C. Ramsey Breakdown of academic impact, for papers by D. C. Villeneuve Breakdown of academic impact, for papers by Clay B. Frederick Breakdown of academic impact, for papers by John Whysner
Rankless by CCL
2026